Scott Litrakis
About Scott Litrakis
Scott Litrakis is the Executive Director of Clinical Compliance & Risk Management at Bristol-Myers Squibb, with extensive experience in clinical compliance and risk management across various therapeutic areas.
Company
Scott Litrakis is currently working at Bristol-Myers Squibb as the Executive Director of Clinical Compliance & Risk Management. He previously held the role of Director in the same department within the organization from 2019 to 2020 for a duration of 7 months.
Previous Roles at Labcorp Drug Development
Prior to his current role, Scott Litrakis spent over a decade at Labcorp Drug Development in various capacities. His tenure included positions such as Senior Director Global Quality Control from 2014 to 2019, Associate Director Quality Control, Project Management and Initiation from 2011 to 2014, Six Sigma Black Belt from 2010 to 2011, and Project Manager from 2006 to 2009. He started his career at the company in various CRA positions from 2000 to 2006.
Education and Expertise
Scott Litrakis earned his M.S. in Experimental Psychology and B.S. in Psychology from Saint Joseph's University. His educational background underpins his extensive experience in clinical compliance, risk management, and quality control in the pharmaceutical industry. He specializes in process improvement and risk management, with a focus on promoting process stability and operational excellence.
Experience in Clinical Compliance and Therapeutic Areas
Throughout his career, Scott Litrakis has managed clinical compliance for various conditions including Bipolar Disorder, Schizophrenia, Type II Diabetes, Deep Venous Thrombosis with Pulmonary Embolism, Dyslipidemia, Hypercholesterolemia, and Homozygous Familial Hypercholesterolemia. He also has experience in managing compliance for oral contraception.